Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-01-02 @ 8:26 AM
Study NCT ID:
NCT04154956
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-05
First Post:
2019-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-05
First Submit QC Date:
None
Study First Post Date:
2019-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-12
Results First Submit QC Date:
None
Results First Post Date:
2024-11-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-24
Last Update Post Date:
2025-08-05
Last Update Post Date Type:
ACTUAL